US Patent 11771733 Lisinopril formulations
Patent 11771733 was granted and assigned to Silvergate Pharmaceuticals, Inc. on October, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 21, 2021
Date of Patent
October 3, 2023
Patent Applicant
Patent Application Number
17507144
Patent Citations
•••
Patent Citations Received
Patent Inventor Names
David W. Miles
Gerold L. Mosher
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11771733 Lisinopril formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.